Bliss GVS Pharma Ltd. benchmarking: Performance to industry peers

Financial

	Bliss GVS Pharma	Novartis	Orchid Pharma
Operational Metrics
Pharmaceuticals
R&D as a % of Total Sales	2.7 %	n/a	n/a
Financials
5 yr Average ROE	6.83 %	8.11 %	4.49 %
5yr average Equity Multiplier	1.3	2.72	1.61
5yr Average Asset Turnover Ratio	0.62	0.18	0.5
5yr Avg Net Profit Margin	8.7 %	17.12 %	0.56 %
Price to Book	2.21	3.19	2.11
P/E	22.98	25.4	142.68
5yr Avg Cash Conversion Cycle	186.56 Days	-23.33 Days	52.03 Days
Inventory Days	54.35 Days	44.27 Days	112.47 Days
Days Receivable	189.93 Days	38.18 Days	86.58 Days
Days Payable	75.78 Days	124.28 Days	159.29 Days
5yr Average Interest Coverage Ratio	14.68	65.43	3.01
5yr Avg ROCE	13.27 %	5.91 %	3.08 %
5yr Avg Operating Profit Margin	17.03 %	15.15 %	11.84 %
5 yr average Debt to Equity	0.11	0.0	0.37
5yr CAGR Net Profit	4.24 %	37.01 %	n/a
5yr Average Return on Assets	5.31 %	3.13 %	1.2 %
Shareholdings
Promoter Holding	35.36 %	70.68 %	69.84 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.9 %	0.0	-20.12 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	15.56 %

	Bliss GVS Pharma	Novartis	Orchid Pharma
Product Wise Break-Up	Product Wise Break-Up Anti Malarials 43.0 Anti-fungal 16.0 Anti Inflammatory 7.0 Antibiotics 5.0 Anti-bacterial 0 0 Sterile 0 Oral Formulations 0 Others 29.0	Product Wise Break-Up Anti-fungal 0 Anti-bacterial 0 Anti Malarials 0 Anti Inflammatory 0 Sterile 0 Antibiotics 0 Wholesale of pharmaceuticals and medical goods 100.0 Oral Formulations 0	Product Wise Break-Up Anti-fungal 0 Anti-bacterial 0 Anti Malarials 0 Anti Inflammatory 0 Sterile 27.56 Antibiotics 0 0 Oral Formulations 72.44
Location Wise Break-Up	Location Wise Break-Up Rest of the World 93.39 India 6.61	Location Wise Break-Up Rest of the World 0 India 100.0	Location Wise Break-Up Rest of the World 0 India 19.9 Others 80.1